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ter; however, its role in apoptosis ofmammalian cells is not fully elucidated. Herewe show that cleav-
age of Scythe by caspase-3 occurs after activation of both the extrinsic (i.e. Fas/APO-1-mediated) and
the intrinsic (i.e. staurosporine-induced) apoptosis pathway. Moreover, this caspase-dependent
cleavage correlateswith Scythe translocation from the nucleus to the cytosol.We also show that cyto-
solic re-localization of Scythe is required for Fas/APO-1-triggered phosphatidylserine (PS) exposure, a
signal for macrophage clearance of apoptotic cells. Our data suggest that Scythe cleavage may repre-
sent amarker for caspase-3 activation and implicate cytosolic re-localization of Scythe in the pathway
of PS exposure.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Apoptosis is a physiological process responsible for the removal
of supernumerary, damaged or harmful cells. This process is criti-
cal for embryonic, development, tissue homeostasis and defense
against pathogens [1]. Generally, it is induced through two major
pathways, an extrinsic pathway and an intrinsic pathway [2]. The
initiation of the extrinsic pathway of apoptosis is triggered via
death receptors on the cell surface, while initiation of the intrinsic
pathway is triggered through activation of mitochondria and re-
lease of pro-apoptotic factors. Hence, death signals induce mito-
chondrial membrane permeabilization and cytochrome c release
and activation of the initiator caspase, caspase-9 [3]. Among the
numerous proteins implicated in apoptosis is Scythe (also known
as BAT3; HLA-B associated transcript; Bag 6). Scythe has been
shown to interact with Reaper, a central regulator of developmen-
tal apoptosis in Drosophila melanogaster, and the interaction be-
tween Scythe and Reaper was shown to be required for Reaper-
induced apoptosis in Xenopus egg extracts [4,5].
A previous study indicated that inactivation of Scythe in the
mouse resulted in lethality associated with pronounced develop-
mental defects in the lung, kidney, and brain [6]. Co-incident withchemical Societies. Published by E
SP, heat shock protein; PS,
-VAD-FMK, N-benzyloxycar-
cular Toxicology, Institute of
nstitutet, 171 77 Stockholm,organogenesis defects was widespread aberrant apoptosis and pro-
liferation, and resistance of Scythe-deﬁcient ﬁbroblasts to
apoptosis.
Scythe also possesses an amino acid sequence that can bind the
ATPase domain of HSP70 family. This region of Scythe has been
shown to interact with HSP70 suggesting that Scythe may function
through regulation of the activity of apoptotic signaling molecules
[7]. Further biochemical evidence that Scythe plays a role in apopto-
sis come from the identiﬁcation of a caspase-3 cleaved Scythe C-ter-
minal fragment, which shows pro-apoptotic activity after its
translocation to the cytosol [8]. Interestingly, among cell stress
inducing reagents such as ricin, cycloheximide, thapsigargin,
tunicamycin, camptothecin, and etoposide, only ricin was found to
cause the cleavage of Scythe and the cytosolic release of the cleaved
fragment, suggesting that the interaction between Scythe and ricin
might promote this proteolytic process [8]. In another study it was
shown that cytosolic Scythe interacts with and regulates the stabil-
ity and location of apoptosis-inducing factor (AIF) after apoptotic
stimulation mediated by endoplasmic reticulum stress [9]. The
aim of the present studywas to determinewhether Scythe cleavage
is a common event during apoptosis. Our data show that cleavage of
Scythe by caspase-3 occurs both after extrinsic and intrinsic activa-
tion of the apoptotic process and that this cleavage is required for
Scythe re-localization to the cytosol since pre-treatment with the
pan-caspase inhibitor Z-VAD-FMKblocked this translocation.More-
over, cytosolic Scythe seems to contribute to PS exposure since
silencing of the expression of this protein results in a signiﬁcant de-
crease of the levels of phosphatidylserine (PS) on the surface of the
apoptotic cells. We propose that the nuclear cleavage of Scythemaylsevier B.V. All rights reserved.
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ization of Scythe appears to play an active role in the pathway lead-
ing to PS exposure in Fas-triggered cells.
2. Materials and methods
2.1. Reagents and cell lines
Agonistic anti-Fas monoclonal antibodies (clone CH-11) were
purchased from Medical & Biological Laboratories, Ltd. (Nagoya,
Japan). Staurosporine, the caspase substrate aspartate-glutamate-
valine-aspartate-7-amino-4-methyl-coumarin (DEVD-AMC), and
the pan-caspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp(O-
Me) ﬂuoromethyl ketone (Z-VAD-FMK), were all purchased from
Sigma (St Louis, MO, USA). The Jurkat human T leukemic cell line,
the Raji human B lymphoma cell line, the U266 myeloma cell line
and the HL-60 promyelocytic leukemia cell line were obtained from
the EuropeanCollection of Cell Cultures (Salisbury, UK) and cultured
in RPMI-1640 medium (Sigma) supplemented with 10–15% heat-
inactivated fetal bovine serum, 2 mM glutamine, 100 U/ml penicil-
lin, and 100 mg/ml streptomycin (Gibco, Paisley, Scotland).
2.2. Caspase-3-like activity
The measurement of DEVD-AMC cleavage was performed in a
ﬂuorometric assay as described previously [10]. The cleavage ofA
B C
Fig. 1. Caspase-3-dependent cleavage of Scythe occurs after extrinsic and intrinsic activa
and U266 cells. Cells were left untreated or treated with Fas mAb (250 ng/ml) or stauro
(20 lM). After 3 h cells were collected and lysed for western blotting. GAPDH was used a
caspase-3-like enzyme activity. Data are presented as the mean ± S.D derived from two
ANOVA). (B) Cleavage of Scythe is mediated by caspase-3 and occurs in the presence o
(250 ng/ml) in the presence or not of the pan-caspase inhibitor Z-VAD-FMK (20 lM) and
and lysed for Western blotting (Scythe, active caspase-3, cleaved PARP and GAPDH as lo
DAPI). (C) Jurkat cells were left untreated or treated with Fas mAb in presence of speciﬁ
blotting. Membranes were re-probed for GAPDH as a control for equal loading of proteithe ﬂuorogenic peptide substrate was monitored in a TECAN
Inﬁnite 200 plate reader (Labsystems, Stockholm, Sweden) using
355 nm excitation and 460 nm emission wavelengths. Fluores-
cence units were converted to pmol of AMC cleavage per minute
based on a standard curve of free AMC.
2.3. Phosphatidylserine exposure
PS exposure was quantiﬁed by dual staining with propidium io-
dide (PI) (Sigma) and Annexin V (Annexin-V-Fluos staining kit,
Roche Diagnostics GmbH, Manheim, Germany) [11]. Cells were
analyzed within 30 min after staining on a FACS Calibur (BD Biosci-
ences, San Jose, CA, USA) operating with CellQuest software (BD
Biosciences).
2.4. Western blotting
For protein detection, western blotting was performed accord-
ing to standard procedures. The following primary antibodies were
used: GAPDH (Ambion, Austin, TX, USA), Scythe (Abcam,
Cambridge, United Kingdom) cleaved caspase-3 (AH Diagnostics,
Stockholm, Sweden), PARP (Biomol International, L.P. Plymouth
Meeting, PA, USA) and Histone H3 (Santa Cruz Biotechnology Santa
Cruz, CA, USA). After washing, the membranes were incubated
with a peroxidase-conjugated secondary antibody (Pierce,
Rockford, IL, USA) and bound antibody was visualized by enhancedtion of apoptosis. (A) Scythe is cleaved in a caspase-dependent manner in Jurkat, Raji
sporine (2 lM) in the presence or absence of the pan-caspase inhibitor Z-VAD-FMK
s loading control. The ﬂuorogenic substrate DEVD-AMC was used for assessment of
independent experiments performed in triplicate. ⁄⁄P < 0.01 ⁄⁄⁄P < 0.001 (one-way
f other signs of apoptosis. Jurkat cells were left untreated or treated with Fas mAb
the speciﬁc caspase-3 inhibitor Z-DEVD-FMK (20 lM). After 3 h cells were collected
ading control) and for immunoﬂuorescence analysis (nuclei are stained in blue by
c inhibitors of caspase 9, 8, 3, and 2 and Scythe cleavage was analysed by western
n.
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cells was performed using the ProteoExtract Subcellular Proteome
Extraction Kit (San Diego, CA, USA).
2.5. RNA interference
ON-TARGETplus Human Scythe (BAT3) siRNA and ON-TARGET-
plusNon-targeting Pool (NC siRNA)werepurchased fromDharmacon
(Lafayette, CO, USA). Jurkat cells were transfected for 48 h with
200 nM siRNA against Scythe or NC in complete growth medium
using the TransIT-TKO Transfection Reagent fromMirusbio (Madi-
son, WI, USA).
2.6. Immunocytochemistry
To analyze cellular localization of Scythe, cells were treated for
3 h with Fas mAb or staurosporine in the presence or absence of
the pan-caspase inhibitor Z-VAD-FMK (1 h pre-incubation). After
incubation at 37 C, cells were attached to glass slides through
cytospin and ﬁxed in PFA 4% for 30 min; then, the slides were rehy-
drated in PBS for 1 h. The rabbit anti-Scythe antibody (H300
sc98519 from Santa Cruz Biotechnology) was added and remained
overnight at 4 C until a brief wash in PBS, after which a secondary
conjugate (Alexa) was added and incubated for 1 h at RT. Then, the
slides were washed and stained with Vecta shield containing 40,6-
diamidino-2-phenylindole (DAPI) (Vector Laboratories Inc., Burlin-
game, CA, USA) and analyzed by confocal microscopy (Leica Micro-
systems, Wetzlar, Germany) as previously described [12] or by an
inverted Nikon ECLIPSE TE2000-S ﬂuorescence microscope (Nikon
Corporation, Kanagawa, Japan) operating with NIS-Elements soft-
ware (Nikon).A
Fig. 2. Cytosolic translocation of Scythe is caspase-dependent and correlates with PS e
treatment in Jurkat and U266 cells but not in Raji or HL-60 cells. The four cell lines were l
cells were collected and ﬁxed for immunoﬂuorescence analysis using a rabbit anti-Scythe
blue by DAPI. (B) The four cell lines were treated as indicated for panel A. After 3 h of
labeling was monitored by ﬂow cytometry. The percentages of Annexin V positive (apo3. Results
3.1. Caspase-3-dependent cleavage of Scythe occurs in extrinsic
and intrinsic apoptosis
Previous studies have revealed the formation of a caspase-3
cleaved C-terminal fragment of Scythe with pro-apoptotic function
after ricin-treatment [8]. This fragment, once translocated to the
cytosol, was capable of inducing PS exposure in HeLa cells. Of note,
amongcell stress inducing reagents including, cycloheximide, thapsi-
gargin, tunicamycin, camptothecin, and etoposide, only ricin was
found to cause the cleavage of Scythe. To determine if cleavage of
Scythe is a general process during apoptosis, we treated Jurkat, Raji
and U266 cells with Fas mAb (extrinsic pathway) and staurosporine
(intrinsic pathway) in presence or not of the pan-caspase inhibitor Z-
VAD-FMK. Western blot analysis showed the formation of a cleaved
band in Fas mAb and staurosporine-treated Jurkat cells, in stauro-
sporine-treated and to some extent in Fas mAb-treated U266 cells
and in Fas mAb-treated but not staurosporine-treated Raji cells.
Moreover, this fragmentwasnot presentwhen cellswerepre-treated
with Z-VAD-FMK (Fig. 1A). It should be noted that Raji cells are re-
ported to be resistant to staurosporine and no caspase activation is
observed after this treatment [13] while U266 cells were shown to
be inherently Fas resistant as a consequence of constitutive activation
of Stat3 [14]. Indeed, we noted that the cleavage of Scythe correlated
with the degree of DEVD-AMC cleavage, indicative of caspase-3 acti-
vation (Fig. 1A). The use of the speciﬁc caspase-3 inhibitor Z-DEVD-
FMK conﬁrmed that Scythe undergoes caspase-3 processing and this
was found to correlate with other signs of apoptosis such as cleavage
of the nuclear caspase-3 substrate, PARP and nuclear condensation/B
xposure. (A) Scythe re-localizes into the cytosol after Fas mAb and staurosporine
eft untreated or treated with Fas mAb (250 ng/ml) or staurosporine (2 lM). After 3 h
antibody to detect the localization of this protein (cf. Fig. 4B). Nuclei are stained in
treatment cells were collected and Annexin V-FITC (AV)–propidium iodide (PI) co-
ptotic) cells are indicated.
A B
Fig. 3. The large Scythe fragment re-localizes to the cytosol of Jurkat but not Raji cells. (A) To study the mechanism of Scythe re-localization after apoptosis induction, Jurkat
and Raji cells were treated with Fas mAb (250 ng/ml) for different time-points and localization of Scythe was studied by immunoﬂuorescence after ﬁxation of the cells in
formaldehyde and incubation with rabbit anti-Scythe antibody (cf. Fig. 4B). (B) Nuclear/cytosolic separation was performed for Raji and Jurkat cells and cell lysates were
probed for Scythe expression. Histone H3 and GAPDH were used as markers to control for nuclear and cytosolic separation of fractions, respectively.
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caspase-9 and caspase-8 also blocked Scythe cleavage, conﬁrming
the importance of the mitochondrial ampliﬁcation loop [15] for acti-
vationof caspase-3 in the prototypical type II cell line, Jurkat (Fig. 1C).
Of note, the caspase-2 inhibitor, VDVAD-FMK did not prevent Scythe
cleavage. Taken together, it appears that cleavage of Scythe by cas-
pase-3occurs both after intrinsic andextrinsic activation of the apop-
totic pathway and can be considered strictly related with the
sensibility to caspase activation upon treatment of cells with pro-
apoptotic agents.
3.2. Caspase-3-dependent cleavage of Scythe is required
for its cytosolic re-localization
Scythe localization during the apoptotic process is debated:
according to one study Scythe is a nuclear protein that contains
an active C-terminal nuclear localization sequence (NLS) and
induction of apoptosis by staurosporine does not cause redistribu-
tion or cleavage of Scythe [16]. Other studies reported that Scythe
re-localizes to the cytosol after thapsigargin treatment [9] or after
ricin-treatment following caspase-3 cleavage [8]. We investigated
the localization of Scythe in four different cell lines, two sensitive
to the Fas signalling pathway (Jurkat and Raji) and two sensitive
to the cytotoxic drug staurosporine (U266 and HL-60). Immunoﬂu-
orescence analysis showed that Scythe, located mainly in the nu-
cleus in control cells, re-localizes to the cytosol in the human T
leukemic cell line Jurkat and in the myeloma cell line U266 after
Fas mAb (250 ng/ml) and staurosporine treatment (2 lM), respec-
tively (Fig. 2A). Moreover, this re-localization is dependent on cas-
pase activation of Scythe since Scythe was retained in the nucleus
after pre-treatment of the cells with the pan-caspase inhibitor Z-
VAD-FMK. This translocation was not observed in Raji cells nor in
HL-60 cells (Fig. 2A) which also failed to present PS externalization
(Fig. 2B). Loss of plasma membrane phospholipid asymmetry and
the following exposure of PS on the cell surface can be considered
a general feature of apoptosis necessary for the removal of apopto-
tic cells by professional phagocytes [17]. Taken together, our data
suggest a link between the caspase-dependent cytosolic re-locali-
zation of Scythe and the ability to present PS on the cell surface,
suggesting an important role of Scythe in the apoptotic processand potentially therefore in the following step of phagocyte re-
moval of the apoptotic corpse.
3.3. The large Scythe fragment re-localizes to the cytosol of
Jurkat cells but not Raji cells
To further elucidate the differences in localization of the
cleaved fragment of Scythe in Jurkat and Raji cells, we studied
the kinetics of Scythe re-localization upon Fas mAb treatment.
We observed that while Scythe is mainly localized in the nuclei
in both Jurkat and Raji cells after 1 h, the difference between these
two cell lines is evident after 3 and 5 h, since in Raji cells, Scythe
remains nuclear while in Jurkat the staining is mainly cytosolic
(Fig. 3A). Previous experiments performed with ricin-treated HeLa
cells indicated that caspase-3 targets the cleavage site, DEQD1001 to
release a small C-terminal fragment (CTF-131) capable, once trans-
located to the cytosol, of inducing PS exposure [8]. To investigate
which fragment of the cleaved Scythe protein translocates to the
cytosol, we performed cytosolic/nuclear separation of cell lysates.
By this approach, we observed that after Fas mAb treatment the
large Scythe fragment (i.e. the amino-terminal part) re-localizes
to the cytosol in Jurkat cells whereas in Raji cells the cleavage
product is apparently retained in the nucleus (Fig. 3B).
3.4. Silencing of Scythe expression reduces PS exposure
in Fas-triggered Jurkat cells
A potential role for cleaved Scythe in the mechanism leading to
apoptosis and attendant PS exposure was noted in a previous study
on ricin-treated HeLa cells [8]. To further conﬁrm an apoptotic role
of Scythe in our model of Fas mAb-treated Jurkat cells we per-
formed knockdown experiments using speciﬁc siRNAs against
Scythe. We controlled the efﬁciency of the silencing by western
blotting analysis as well as by immunoﬂuorescence analysis
(Fig. 4A). It should be underlined that the antibody used here to
study Scythe localization by immunoﬂuorescence (clone H300
Santa Cruz) detects an epitope of the protein corresponding to ami-
no acids 833–982 (Fig. 4B). Since the caspase-3 cleavage site is
DEQD1001 [8] the observed cytosolic staining in Fas mAb- and
staurosporine-treated cells (Fig 2A) provides further conﬁrmation
A B
C
Fig. 4. Silencing of Scythe reduces PS exposure in Fas mAb-treated Jurkat cells. (A) Jurkat cells were transfected with 200 nM siRNA for Scythe and non-targeting siRNA (NC).
After 48 h cells were collected for western blotting and immunoﬂuorescence analysis to detect the levels of Scythe. GAPDH was used as loading control. (B) Schematic
diagram depicting the caspase-3 cleavage motif within the Scythe sequence [8] and the different epitopes recognized by the two anti-Scythe antibodies used in the present
study. The nuclear localization signal (NLS) is also indicated. (C) Jurkat cells transfected as in panel A were left untreated or treated with Fas mAb (50 ng/ml). After 3 h, cells
were collected and Annexin V staining was performed.
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the cytosol. To establish whether Scythe plays an active role in the
mechanism leading to PS exposure we performed Annexin V stain-
ing in Jurkat Fas mAb-treated cells. Annexin V labeling revealed a
decrease in PS exposure in Jurkat cells with knockdown of Scythe
compared to wild-type cells or cells treated with non-targeting
siRNA (Fig. 4C). These data, together with the observation that a
lack of PS exposure is observed in cells which retain Scythe in
the nucleus (Fig. 2 A and B) clearly show that the redistribution
of Scythe to the cytosol is required for apoptotic PS exposure.
4. Discussion
The present ﬁndings suggest that the nuclear protein Scythe is a
target for caspase-3 cleavage in extrinsic and intrinsic apoptosis.
Cleavage of Scythe in Fas mAb-treated Jurkat cells is inhibited by
the pan-caspase inhibitor Z-VAD-FMK and by speciﬁc inhibitors
of caspase 3, 8, and 9 which conﬁrms the importance of the mito-
chondrial ampliﬁcation loop for type II cells [18]. Moreover cleav-
age of Scythe is required for its cytosolic re-localization. We also
found that this cytosolic re-localization is related to the ability of
apoptotic cells to expose PS on the outer surface of the cell since
the two cell lines (Raji and HL-60) which failed to re-localize
cleaved Scythe to the cytosol were also deﬁcient in PS exposure,
in line with our previous studies [13]. Moreover, silencing of
Scythe expression in Jurkat cells conﬁrmed a role for cytosolic
Scythe in the pathway leading to PS exposure upon ligation of
the Fas receptor. The use of an antibody directed against a speciﬁc
epitope of the protein (aa 833–982) together with cytosolic/nucle-
ar separation of cell lysates identiﬁed the larger Scythe fragment as
the one that re-localizes to the cytosol. Our data suggest that cas-
pase-3-mediated cleavage of Scythe serves to remove the nuclear
localization sequence (aa 1030–1050) [16], allowing the larger
fragment to re-localize to the cytosol. However, further studies
are warranted to determine the exact mechanism by which cyto-
solic Scythe contributes to PS exposure. In conclusion, this studyimplicates Scythe as a common target of caspase-3 and proposes
a role for Scythe in the regulation of PS exposure, a signal for apop-
totic corpse clearance by phagocytes [17]. Identiﬁcation of new
players in the multifaceted process of apoptosis can lead to devel-
opment of new strategies for treatment of many disorders, includ-
ing cancer, autoimmune and neurodegenerative diseases.
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